Van Naarden Jacob 4
4 · ELI LILLY & Co · Filed Feb 12, 2025
Insider Transaction Report
Form 4
Van Naarden Jacob
EVP,Pres LLY Oncology&HdCorpBD
Transactions
- Award
Common Stock
2025-02-10$868.88/sh+6,103.824$5,303,491→ 19,561.985 total - Award
Restricted Stock Unit
2025-02-10+4,108→ 4,108 totalFrom: 2026-02-01Exp: 2026-02-01→ Common Stock (4,108 underlying)
Holdings
- 4,342(indirect: By Trust)
Common Stock
- 4,302(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.